AI assistant
AtriCure, Inc. — Director's Dealing 2012
Sep 7, 2012
31802_dirs_2012-09-07_8622eac7-0907-4f1c-8b41-265f0e9a0936.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-09-05
Reporting Person: Drachman David J (President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-05 | Common Stock | S | 50000 | $6.55 | Disposed | 334983 | Direct |
| 2012-09-06 | Common Stock | S | 180583 | $6.53 | Disposed | 154400 | Direct |
| 2012-09-07 | Common Stock | S | 8400 | $6.80 | Disposed | 146000 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $6.50 to $7.03 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $6.50 to $6.79 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $6.79 to $6.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.